SCHEMBL5401566

SCHEMBL5401566

CCOc1ccc(Br)cc1NC(=O)Nc1ccc(-n2ccnc2-c2ccncc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.49
KDR P35968 2/20 0.44
EPHB4 P54760 1/20 0.44
TEK Q02763 1/20 0.44
MAPT P10636 6/20 0.42
MEN1 O00255 4/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
LMNA P02545 3/20 0.42
HTT P42858 2/20 0.42
RAB9A P51151 2/20 0.42
TP53 P04637 1/20 0.42
FPR2 P25090 2/20 0.42
HRH3 Q9Y5N1 1/20 0.42
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 2/20 0.40
NPC1 O15118 1/20 0.40
CREBBP Q92793 1/20 0.39
PTPN2 P17706 1/20 0.39
PTPN1 P18031 1/20 0.39
PTPN6 P29350 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4332999 0.91 KDR (0.51) KMT2AKDREPHB4TEKMAPT
SCHEMBL4324533 0.90 KMT2A (0.41) KMT2AKDREPHB4TEKMAPT
SCHEMBL4328559 0.81 EPHB4 (0.51) KMT2AKDREPHB4TEKMAPT
SCHEMBL4330725 0.81 MAPT (0.56) KMT2AEPHB4MAPTMEN1SMN1; SMN2
SCHEMBL4323333 0.81 EPHB4 (0.46) KMT2AKDREPHB4TEKMAPT
SCHEMBL4333755 0.80 EPHB4 (0.48) KMT2AKDREPHB4TEKMAPT
SCHEMBL4321433 0.80 KMT2A (0.52) KMT2AEPHB4MAPTMEN1SMN1; SMN2
SCHEMBL4321789 0.79 CYP1A2 (0.49) KMT2AKDREPHB4TEKMAPT
SCHEMBL4318354 0.78 RAF1 (0.55) KDREPHB4TEKMAPTSMN1; SMN2
SCHEMBL4331851 0.78 MAPT (0.53) KMT2AKDREPHB4MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1858877-A1 1,3 SUBSTITUTED DIARYL UREAS AS MODULATORS OF KINASE ACTIVITY CGI Pharmaceuticals, Inc. (US) 2007-11-28 EP disclosed
WO-2006076592-A1 1,3 SUBSTITUTED DIARYL UREAS AS MODULATORS OF KINASE ACTIVITY CGI PHARMACEUTICALS, INC. (US) 2006-07-20 WO disclosed